Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: mNGS diagnosis of pediatric infectious disease

PROVIDER: PRJNA662682 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12635522_1.fastq.gz	Fastqsanger.gz
	SRR12635522_2.fastq.gz	Fastqsanger.gz
	SRR12635523_1.fastq.gz	Fastqsanger.gz
	SRR12635523_2.fastq.gz	Fastqsanger.gz
	SRR12635524_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 325

Similar Datasets

Project description:diagnosis of infectious peripheral pulmonary lesions by mNGS

| PRJNA663652 | ENA

Whole blood transcriptional profiles of patients with active tuberculosis (TB) and other inflammatory and infectious diseases

Project description:Tuberculosis (TB), caused by infection with Mycobacterium tuberculosis (M. tuberculosis), is a major cause of morbidity and mortality worldwide and efforts to control TB are hampered by difficulties with diagnosis, prevention and treatment. Most people infected with M. tuberculosis remain asymptomatic, termed latent TB, with a 10% lifetime risk of developing active TB disease, but current tests cannot identify which individuals will develop disease. The immune response to M. tuberculosis is complex and incompletely characterized, hindering development of new diagnostics, therapies and vaccines. The goals of this study include: 1. Identify a transcript signature for active TB in intermediate and high burden settings, correlating with radiological extent of disease and reverting to that of healthy controls following treatment; 2. Identify a specific transcript signature that discriminated active TB from other inflammatory and infectious diseases; 3. Classify TB signature using modular and pathway analysis tools. Three milliliters of whole blood was collected in Tempus tubes from 12 pediatric streptococcus, 40 pediatric staphylococcus, 31 still’s disease, 82 pediatric systemic lupus erythematosus (SLE) and 28 adult SLE patients. RNA was extracted and globin reduced. Labeled cRNA was hybridized to Illumina Human HT-12 Beadchips. Healthy controls were included to match patients’ demographic data. Genespring software was used to analyze active TB transcript signatures, comparing with healthy controls and other inflammatory and infectious diseases.

2010-08-11 | E-GEOD-22098 | biostudies-arrayexpress

human metagenome

Project description:Metagenomic Next-Generation Sequencing for Infectious Disease Diagnosis

| PRJNA298217 | ENA

Project description:Trypanosoma brucei diagnosis using mNGS

| PRJNA950479 | ENA

Project description:mNGS for the diagnosis of sepsis

| PRJNA705546 | ENA

Project description:Application of mNGS in intractable infectious diseases

| PRJNA706470 | ENA

Project description:Rapid diagnosis of alveolar echinococcosis by mNGS

| PRJNA1077456 | ENA

human blood metagenome

Project description:Diagnosis of infectious diseases by sequencing

| PRJDB7111 | ENA

Harnessing Bronchoalveolar Lavage Metagenomics for Distinguishing Lung Cancer from Pulmonary Infectious Diseases

Project description:Recent progress in unbiased metagenomic next-generation sequencing (mNGS) allows simultaneous examination of microbial and host genetic material in a single test. Leveraging affordable bronchoalveolar lavage fluid (BALF) mNGS data, we employed machine learning to create a diagnostic approach distinguishing lung cancer from pulmonary infections, conditions prone to misdiagnosis in clinical settings. This prospective study analyzed BALF-mNGS data from lung cancer and pulmonary infection patients, delineating differences in DNA/RNA microbial composition, bacteriophage abundances, and host responses, including gene expression, transposable element levels, immune cell composition, and tumor fraction derived from copy number variation (CNV). Integrating these metrics into a host/microbe metagenomics-driven machine learning model (Model VI) demonstrated robustness, achieving an AUC of 0.87 (95% CI = 0.857-0.883), sensitivity = 73.8%, and specificity = 84.5% in the training cohort, and an AUC of 0.831 (95% CI = 0.819-0.843), sensitivity = 67.1%, and specificity = 94.4% in the validation cohort for distinguishing lung cancer from pulmonary infections. The application of a rule-in and rule-out strategy-based composite predictive model significantly enhances accuracy (ACC) in distinguishing between lung cancer and tuberculosis (ACC=0.913), fungal infection (ACC=0.955), and bacterial infection (ACC=0.836). These findings highlight the potential of cost-effective mNGS-based analysis as a valuable tool for early differentiation between lung cancer and pulmonary infections, offering significant benefits through a single comprehensive testing.

2024-01-08 | GSE252118 | GEO

aCGH of a pediatric acute lymphoblastic leukemia cohort

Project description:Array comparative genomic hybridization data for 372 diagnosis pediatric acute lymphoblastic leukemia samples.

2023-03-13 | GSE184692 | GEO